On the other hand, though other malignancy risk factors such as tumor invasion, lymph node metastasis and vascular invasion showed no significant relation with MLL2 expression, there was a tendency that patients with deeper invasion, lymph node metastasis and vascular invasion appeared to have a higher expression rate of MLL2. The gene discussed is KMT2D; the disease is neoplasm.